Corestreet Logo

PTC Therapeutics Inc (PTCT) Insider Trading

Total insider buys:
  • $31,673,582.00
Total insider sells:
  • $179,522,421.48
Most recent insider trade:
  • April 6, 2026
Most active insider trader:
  • Mark Elliott Boulding
Trader NameDateTitleAmountPriceTypeTotal Value
May 22, 2015CFO82,491$55.41Sell$4,570,826.31
April 15, 2015EVP9,511$68.65Sell$652,930.15
March 23, 2015CEO47,200$69.14Sell$3,263,408.00
March 23, 2015Director2,317$69.04Sell$159,965.68
March 20, 2015VP21,142$68.12Sell$1,440,193.04
March 18, 2015Director16,616$76.00Sell$1,262,816.00
March 17, 2015Insider10,700$76.64Sell$820,048.00
March 16, 2015Director2,500$72.81Sell$182,025.00
March 13, 2015Insider1,030$75.10Sell$77,353.00
March 10, 2015EVP79$70.71Sell$5,586.09
March 9, 2015CEO47,201$70.74Sell$3,338,998.74
Feb. 25, 2015Insider35,000$68.01Sell$2,380,350.00
Feb. 24, 2015Insider1,000$67.70Sell$67,700.00
Feb. 23, 2015Insider23,000$65.40Sell$1,504,200.00
Jan. 21, 2015EVP26,096$60.26Sell$1,572,544.96
Jan. 20, 2015Insider3,000$60.02Sell$180,060.00
Jan. 16, 2015Insider2,300$58.67Sell$134,941.00
Jan. 15, 2015President2,149$57.19Sell$122,901.31
Jan. 14, 2015Insider9,700$58.04Sell$562,988.00
Dec. 15, 2014President2,173$55.24Sell$120,036.52
Nov. 17, 2014President2,173$39.78Sell$86,441.94
Oct. 15, 2014President45,661$36.15Sell$1,650,645.15
Oct. 10, 2014President43,489$36.18Sell$1,573,432.02
Oct. 1, 2014CEO41,501$42.65Sell$1,770,017.65
Sept. 26, 2014Insider16,000$44.63Sell$714,080.00
Sept. 18, 2014Director2,000$40.16Sell$80,320.00
Sept. 15, 2014Insider8,000$36.24Sell$289,920.00
May 22, 2014CFO1,650$14.74Sell$24,321.00
March 24, 2014CEO25,487$29.86Sell$761,041.82
March 21, 2014Director2,317$30.93Sell$71,664.81
March 21, 2014President15,320$29.61Sell$453,625.20
March 20, 2014VP10,049$30.96Sell$311,117.04
March 19, 2014VP10,859$31.91Sell$346,510.69
March 18, 2014Director7,616$31.18Sell$237,466.88
March 14, 2014Director1,186$31.02Sell$36,789.72
March 13, 2014Insider1,186$31.75Sell$37,655.50
March 7, 2014CEO27,414$29.91Sell$819,952.74
Dec. 17, 2013major shareholder66,667$19.08Sell$1,272,006.36
June 25, 2013Insider25,000$15.00Buy$375,000.00
June 25, 2013Major Shareholder666,676$15.00Buy$10,000,140.00
June 25, 2013Director1,250,000$15.00Buy$18,750,000.00
First«5 of 5»Last

  • Insiders are both buying and selling PTC Therapeutics Inc stock.

  • The insider traders at PTC Therapeutics Inc are: Mark Elliott Boulding, Stuart Walter Peltz, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Allan Steven Jacobson, Mark Rothera, Lee Scott Golden, Stephanie Okey, David P Southwell, Claudia De Oliveira Ri Hirawat, Pierre Gravier, Marcio Souza, Dawn Svoronos, Emma Reeve, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Michael Schmertzler, Shane William Charles Kovacs, Alethia Young, Matthew B. Klein, Adam Koppel, Richard Aldrich, Robert J Spiegel, Robert Spiegel, David Southwell, Michael Kranda, and Michael L Kranda

  • The most active insider trader at PTC Therapeutics Inc is Mark Elliott Boulding with 34 trades.

  • Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.

  • Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.

  • The most recent insider trade for PTC Therapeutics Inc was on April 6, 2026.

  • The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.

  • The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.